Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression

Concurrent activation of RAS/ERK and PI3K/AKT pathways is implicated in prostate cancer progression. The negative regulators of these pathways, including sprouty2 (SPRY2), protein phosphatase 2A (PP2A), and phosphatase and tensin homolog (PTEN), are commonly inactivated in prostate cancer. The molec...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Patel, Rachana, Gao, Meiling, Ahmad, Imran, Fleming, Janis, Singh, Lukram B., Rai, Taranjit Singh, McKie, Arthur B., Seywright, Morag, Barnetson, Robert J., Edwards, Joanne, Sansom, Owen J., Leung, Hing Y.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Clinical Investigation 2013
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3582117/
https://ncbi.nlm.nih.gov/pubmed/23434594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI63672
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller